HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
1 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PSME3IP1
proteasome activator subunit 3 interacting protein 1
Chromosome 16 · 16q13
NCBI Gene: 80011Ensembl: ENSG00000172775.19HGNC: HGNC:29856UniProt: Q9GZU8
59PubMed Papers
16Diseases
0Drugs
0Pathogenic Variants
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
negative regulation of proteasomal protein catabolic processnucleusnucleoplasmnegative regulation of protein bindingneoplasmosteoporosisarthritiscoronary atherosclerosis
✦AI Summary

Based on limited published evidence, PSME3IP1 (also known as NIP30) promotes association of the proteasome activator PSME3 with the 20S proteasome while inhibiting PSME3-mediated substrate degradation by regulating substrate diffusion into the catalytic chamber 1. It also inhibits PSME3-COIL interaction and suppresses PSME3 accumulation in Cajal bodies while positively regulating Cajal body number. PSME3IP1 functions as a negative regulator of proteasomal protein catabolic processes and protein binding, localizing to the nucleoplasm and nucleus with roles in mRNA splicing.

Sources cited
1
NIP30 (PSME3IP1) inhibits REGγ-proteasome activity through serine phosphorylation and regulates chemotherapy sensitivity in p53-deficient tumor cells
PMID: 32764536
⚠Limited data available — This gene has 1 indexed publication. Summary and analysis may be incomplete.
Disease Associationsⓘ16
neoplasmOpen Targets
0.05Suggestive
osteoporosisOpen Targets
0.04Suggestive
arthritisOpen Targets
0.02Suggestive
coronary atherosclerosisOpen Targets
0.02Suggestive
cancerOpen Targets
0.01Suggestive
Alzheimer diseaseOpen Targets
0.01Suggestive
depressive disorderOpen Targets
0.00Suggestive
hypertensionOpen Targets
0.00Suggestive
muscle atrophyOpen Targets
0.00Suggestive
squamous cell carcinomaOpen Targets
0.00Suggestive
viral diseaseOpen Targets
0.00Suggestive
cervical cancerOpen Targets
0.00Suggestive
esophageal cancerOpen Targets
0.00Suggestive
gastric cancerOpen Targets
0.00Suggestive
glioma susceptibility 1Open Targets
0.00Suggestive
ovarian serous cystadenocarcinomaOpen Targets
0.00Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
PPIEProtein interaction100%XAB2Protein interaction100%RBM22Protein interaction100%CDC5LProtein interaction100%BCAS2Protein interaction100%PRPF19Protein interaction100%
Tissue Expression6 tissues
Brain
100%
Bone Marrow
63%
Lung
42%
Heart
42%
Ovary
40%
Liver
39%
Gene Interaction Network
Click a node to explore
PSME3IP1PPIEXAB2RBM22CDC5LBCAS2PRPF19
PROTEIN STRUCTURE
Preparing viewer…
PDB7W59 · 3.60 Å · EM
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.68LoF Tolerant
pLIⓘ
0.20Tolerant
Observed/Expected LoF0.43 [0.28–0.68]
RankingsWhere PSME3IP1 stands among ~20K protein-coding genes
  • #7,804of 20,598
    Most Researched59
  • #5,005of 17,882
    Most Constrained (LOEUF)0.68
Genes detectedPSME3IP1
Sources retrieved1 papers
Response time—
📄 Sources
1
1
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.
PMID: 32764536
Nat Commun · 2020
1.00